Overview

A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Primary Objective : To evaluate the effect of ticagrelor tablets on the pharmacokinetic characteristics of YZJ-1139 in healthy subjects; Secondary Objective: To evaluate the safety of ticagrelor tablets in combination with YZJ-1139 tablets in healthy subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Treatments:
Ticagrelor